PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 85: Articles 42001-42573 (573 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Varying views on the reliability of periodic abstinence as a method of contraception. [Die Meinungsverschiedenheiten uber die Zuverlassigkeit der periodischen Abstinenz als Methode der Empfangnis-verhutung.]
  2. Vascular headaches and oral contraceptives.
  3. Voluntary organisations and family planning.
  4. What is the guiding principle in family planning.
  5. Wy 3707, a totally synthesized progestogen for contraception. (Norgestrel)
  6. Contraception with intrauterine plastic loops.
  7. Evaluation of use of an injectable progestin-estrogen for contraception.
  8. Family planning programs today: major themes of the Geneva conference.
  9. A new oral contraceptive.
  10. Pronuclear ovum from a patient using an intrauterine contraceptive device.
  11. Relative antifertility activity of three vaginal contraceptive products in the rabbit: relationship to in vitro data.
  12. Abortion, contraception, and population policy in the Soviet Union.
  13. Absence of hepatic impairment in long-term oral-contraceptive users.
  14. Acceptance of an oral contraceptive program in a large metropolitan area.
  15. Action Program of family planning in Puerto Rico.
  16. Action Programs of family planning in Japan.
  17. Aerosol foam: a practical and effective method of contraception.
  18. Birth control in Lima, Peru: attitudes and practices.
  19. Cerebrovascular accidents and oral contraception. (Letter to the editor)
  20. Classification of oral contraceptives.
  21. Clinical application of oral contraceptives.
  22. Clinical assessment of oral contraceptives.
  23. Clinical evaluation of the oral contraceptive use of norethindrone 5 mg. plus mestranol 0.075 mg.
  24. Clinical experience with three intra-uterine contraceptive devices.
  25. Clinical studies (Oral contraceptives)
  26. Clinical study of tailed and non-tailed intra-uterine contraceptive devices. (Abstract only)
  27. Clinical use of oral contraception.
  28. Clinical use of oral contraception.
  29. Communication in family planning.
  30. Comparative study of two intra-uterine contraceptive devices. (Abstract only)
  31. Complications of oral contraception.
  32. Contraception and therapy with Ovulen. [Konzeptionsverhutung und Therapie mit Ovulen.]
  33. Contraceptive drugs.
  34. Contraceptive effect of plastic devices in cattle uteri.
  35. Control of fertility in Taichung, Taiwan, by using intra-uterine contraceptive devices: medical follow-up.
  36. Current developments in systemic contraception.
  37. Current experience with an intra-uterine contraceptive device.
  38. Current research on new contraceptive methods.
  39. Cytological and histological studies after prolonged use of intra-uterine contraceptive devices. (Abstract only)
  40. Cytological studies after insertion of intrauterine contraceptive devices.
  41. Do oral contraceptives have neuro-ophthalmic complications?
  42. Effect of intra-uterine contraceptive device on uterine motility. (Abstract only)
  43. Effect of intra-uterine contraceptive devices on brush smears of the endometrial cavity. (Abstract only)
  44. Effect of oral contraceptives on the ovarian reaction to human gonadotropins in amenorrheic women.
  45. The effect of the intra-uterine contraceptive coil on the oviducts. (Abstract only)
  46. Erythema nodosum associated with the use of an oral contraceptive: report of a case.
  47. Evaluating community family planning programs.
  48. An evaluation of intra-uterine contraceptive devices. (Abstract only)
  49. Evaluation of the family planning programme in India: report of the panel of consultants.
  50. An evaluation of the intra-uterine contraceptive device in a group of 50 women. (Abstract only)
  51. Experience with intra-uterine contraceptive devices. (Abstract only)
  52. Experience with intra-uterine contraceptive devices. (Abstract only)
  53. Experience with oral and intrauterine contraception in rural Puerto Rico.
  54. Experience with plastic intra-uterine contraceptive devices (Lippes loop s) in Egypt. (Abstract only)
  55. Experimental studies on intra-uterine contraception. (Abstract only)
  56. Extent of use of contraception.
  57. Family design: marital sexuality, family size, and contraception.
  58. Family planning clinic programme in Bombay.
  59. Family planning enquiry in Dharwar taluka (Mysore State): a survey conducted in Dharwar Town and twenty villages of Dharwar taluka.
  60. Family planning enquiry in rural Shimoga (Mysore State): a survey conducted in a region currently experiencing a high rate of growth in population.
  61. Family planning for maternal and child health.
  62. Family planning in Lima, Peru.
  63. Family planning programme.
  64. Family planning programmes in Taiwan.
  65. First experiences with a new oral contraceptive. [Erste Erfahrungen mit einem neuen oralen Antikonzeptivum.]
  66. The first five years of contraceptive service in a municipal hospital.
  67. Genital tract infection with an intra-uterine contraceptive device: a histopathologic study.
  68. History and statistical evaluation of intrauterine contraceptive devices.
  69. History of contraceptive methods.
  70. History of the development of present-day oral contraception.
  71. Hormonal contraception. [Hormonell antikonsepsjon.]
  72. Hormone excretion patterns during and after the long-term administration of oral contraceptives.
  73. Human precarcinogenic cell manifestations associated with polyethylene contraceptive device.
  74. The importance of stiffness in intra-uterine contraceptive devices. (Abstract only)
  75. Increasing the size of the nulliparous uterus for insertion of a contraceptive device. (Abstract only)
  76. India's family planning program: some lessons learned.
  77. Influence of two contraceptives on induction of mammary cancer in rats.
  78. Inhibition of ovulation using gestagens and its importance for contraception. [Die Hemmung der Ovulation durch Gestagene und ihre Bedeutung fur die Schwangerschaftsverhutung.]
  79. Intra-uterine contraception in Southern Rhodesia. (Abstract only)
  80. Intra-uterine contraception in the postpartum patients of a large maternity hospital: preliminary report.
  81. Intra-uterine contraception with the use of a flexible nylon ring: experience in Santiago De Chile.
  82. Intra-uterine contraception: effectiveness and acceptability.
  83. Intra-uterine contraception: research report.
  84. Intra-uterine contraceptive devices.
  85. Intrauterine contraceptive devices: a method of localization.
  86. Jaundice during treatment with an oral contraceptive, Lyndiol.
  87. Liver metabolism and contraceptive steroids.
  88. Liver-function tests during intake of contraceptive tablets in pre-menopausal women.
  89. The long-term use of Ovulen for contraception.
  90. Long-term use of various types of intra-uterine contraceptive devices in women of high fertility. (Abstract only)
  91. The Margulies intrauterine contraceptive device: experience with 623 women.
  92. The marital and sexual adjustment of 330 couples who chose vasectomy as a form of birth control.
  93. The mechanism of action of oral contraceptives and their side effects in clinical practice.
  94. Mechanism of action of the intra-uterine contraceptive device in the primate. 1. Tubal transport of ova and distribution of spermatozoa.
  95. Mechanism of oral contraception.
  96. Medical aspects of oral contraceptives. (Letter to the editor)
  97. Medical indications for contraception: changing viewpoints.
  98. Medicine and the Law: thrombosis and oral contraceptives.
  99. Mode of action of oral contraceptives.
  100. Motivation, communications research, and family planning.
  101. Myalgia and an oral contraceptive.
  102. The national family planning program in Korea.
  103. A new simple contraceptive device. [Ujtipusu egyszeru fogamzasgatlo eszkoz.]
  104. Oral contraception and carcinoma.
  105. Oral contraception and liver-function tests.
  106. Oral contraception with hormonal tablets.
  107. Oral contraception.
  108. Oral contraception. [Contraception orale.]
  109. Oral contraceptive hormones and blood coagulability.
  110. Oral contraceptives and acute intermittent porphyria. (Letter to the editor)
  111. Oral contraceptives and cerebral arterial occlusion.
  112. Oral contraceptives and coronary thrombosis.
  113. Oral contraceptives and coronary thrombosis. (Letter to the editor)
  114. Oral contraceptives and liver damage.
  115. Oral contraceptives and liver damage.
  116. Oral contraceptives and neuro-ophthalmologic interest.
  117. Oral contraceptives and thromboembolic episodes.
  118. Oral contraceptives and thromboembolic episodes.
  119. Oral contraceptives in porphyria variegata.
  120. Organizational structures in family planning programs.
  121. Parameters of the menstrual cycle and the efficiency of rhythm methods of contraception.
  122. Population growth and family planning in Latin America.
  123. The potential role of the Turkish village opinion leaders in a program of family planning.
  124. The potential role of Turkish village opinion leaders in a program of family planning.
  125. Practical issues for the doctor prescribing oral contraceptives.
  126. Practice of birth control: a study of 1,000 women in Manila.
  127. Pregnancy and progeny after use of progestin-like substances for contraception.
  128. Present status of contraception. [Gegenwartiger Stand der Antikonzeption.]
  129. The program for intra-uterine contraceptive devices in Taiwan: development, setting, and evaluation.
  130. Proposals for family planning promotion: a marketing plan.
  131. A psychoanalytic study of contraception.
  132. Recent advances in contraceptive techniques.
  133. Recent developments in public health family planning programs in the United States.
  134. Relation of arterioles in the endometrium to headache from oral contraceptives. (Letter to the editor)
  135. Report on the programme of I.U.C.D. method of family planning in New Delhi by the New Delhi Family Planning Association from January 1965 to July 1965.
  136. Retention of intrauterine contraceptive device during and after delivery.
  137. Some elements of evaluating the problem of family planning and the fight against abortions (author's transl) [Neki elementi evaluacije problema planiranja porodice i borbe protiv pobacaja.]
  138. Sterilization and family planning.
  139. Sterilization, oral contraception, and population control in China.
  140. Studies concerning family planning. [Etudes concernantes la planification de la famille.]
  141. Studies of family planning in the Quinta Normal district of Santiago; the use of contraceptives.
  142. Studies of the endometrium in patients using intra-uterine contraceptive devices. 1. Histologic changes in the uterus.
  143. Studies of the endometrium in patients using intra-uterine contraceptive devices. 2. Evaluation of bacteriologic methods in culturing endometrial tissue.
  144. A study of intra-uterine contraception in Los Angeles clinics. (Abstract only)
  145. Study of tissue reaction in hysterectomy specimens removed after insertion of intra-uterine contraceptive devices. (Abstract only)
  146. Summary of Eighth National Survey on Family Planning.
  147. Three cases of intravascular thrombosis occurring in patients receiving oral contraceptives.
  148. Tokos and atokion: an examination of natural law reasoning against usury and against contraception.
  149. Trial of a new form of oral contraceptive.
  150. Use of a liquid silicone polymer for intra-uterine contraception. (Abstract only)
  151. The use of intra-uterine contraceptives by 72 general practitioners in 32 countries. (Abstract only)
  152. The use of mobile clinics for the introduction of intra-uterine contraceptive devices.
  153. Uterine cavity measurements in relation to design of intra-uterine contraceptive devices.
  154. Vaginal contraception--a necessity.
  155. A vaginal contraceptive foam.
  156. Vertebral-artery thrombosis and oral contraceptives.
  157. 2 mg. norethindrone-mestranol in contraception and therapy.
  158. 30 years experience with intra-uterine contraceptive devices.
  159. Acceptance of oral contraception by private patients.
  160. Availability and manufacture of contraceptives in South East Asia.
  161. The Birnberg bow as an intra-uterine contraceptive. (Abstract only)
  162. Birth control and population policy.
  163. Birth control in China.
  164. Birth control methods, a reassessment.
  165. Blood coagulability and oral contraception.
  166. Can the Church change her position on birth control?
  167. Cerebrovascular accidents and oral contraception. (Letter to the editor.)
  168. Cerebrovascular accidents and oral contraception. (Letter to the editor.)
  169. Clinical experience in the use of oral contraceptives.

     

  170. Comparative statistics on a variety of oral contraceptive preparations.
  171. A comparative study of low dosage oral contraceptives.
  172. Comparison of two contraceptive methods: jelly or cream alone, and diaphragm with jelly or cream.
  173. Complete document on the procedure and results of the family planning programme in the Japanese national railways: a sample of guidance for large population groups.
  174. Conclusion (about possible relationship between feminism and family planning)
  175. Conscience and contraception.
  176. Contraception and the medical profession.
  177. Contraception and the philosophy of process.
  178. Contraception. 2. Hormonal contraception. [Zur Frage der Kontrazeption. Teil 2. Hormonale Kontrazeption.]
  179. Contraceptive effect of oral progestins: properties of SC-11800, a new oral ovulation inhibitor.
  180. Contraceptive efficacy of norethindrone with mestranol.
  181. The contraceptive industry and its environment.
  182. Contraceptives as a means of combating illegal abortions.
  183. Current status of oral contraception.
  184. The doctor's role in family planning.
  185. The effect of an intrauterine contraceptive device on the bacterial flora of the endometrial cavity.
  186. Effectiveness of a low-dose oral contraceptive tablet.
  187. Eight years' experience with oral contraception and an analysis of use of low-dosage norethisterone.
  188. Emotional aspects of family planning.
  189. Endometrial effects of mestranol-norethindrone sequential therapy for oral contraception.
  190. Endometrial histology and vaginal cytology during oral contraception with sequential estrogen and progestin.
  191. Extensive use of the volunteer in a family planning programme.
  192. Family planning a great need.
  193. Family planning and agricultural migrant workers: a case study.
  194. Family planning and poverty.
  195. Family Planning Association of Hong Kong: education and social work programme.
  196. Family planning education via pamphlets.
  197. Family planning education with special regard to working mothers.
  198. Family planning in a rural area: a search for an approach.
  199. Family planning in rural India: a problem in social change.
  200. The family planning movement in relation to the level of living and abortion in Japan - from the view point of quality of population.
  201. Family planning needed in Uruguay. [La planificacion familiar que requiere Uruguay.]
  202. The family planning program in India. Excerpts from the director's Annual report.
  203. Family planning training programmes. (Report of study group 6)
  204. Family-planning knowledge and attitude surveys in Pakistan.
  205. Fertility and birth control in developed societies, and some questions o f policy for less developed societies.
  206. Freedom of choice (Family planning)
  207. Hepatic impairment during the intake of contraceptive pills: clinical trial with postmenopausal women.
  208. Hypotheses for family planning derived from recent and current experience in Asia.
  209. Impact of new methods on practice in 73 planned parenthood centers.
  210. Intra-uterine contraception in India.
  211. Intra-uterine contraception.
  212. Intrauterine contraception: A New Approach.
  213. Introduction (to feminism and family planning in Victorian England)
  214. Introductory paper on methods of contraception.
  215. K.S. Contraceptive Wing.
  216. Medical handbook. Pt. 1. Contraception. 2nd. ed. Revised and enlarged.
  217. Methods of birth control: a reassessment.
  218. National family planning programs: A guide.
  219. The National Intra-uterine Contraceptive Device Evaluation Program of Pakistan.
  220. New oral contraceptive: sequential estrogen and progestin.
  221. Newer drugs in oral contraception.
  222. Norethindrone and mestranol: experience in private practice with a new low-dosage oral contraceptive.
  223. Oral contraception and liver damage. (Letter to the editor.)
  224. Oral contraception and liver damage. (Letter to the editor.)
  225. Oral contraception. A clinical study of Enavid. [Peroral antikonception. En klinisk undersogelse over Enavid.]
  226. Oral contraceptive problems in Japan.
  227. Oral contraceptives and breast cancer.
  228. Oral contraceptives and breast cancer.
  229. Oral contraceptives and breast cancer. (Letter to the editor)
  230. Oral contraceptives and liver damage. (Letter to the editor.)
  231. Oral-contraceptive feminization of a normal male infant: report of a case.
  232. Our experiences with oral contraceptives using progestagens. [Nase zkusenosti s peroralni antikoncepci progestageny.]
  233. Pakistan: the Rural Pilot Family Planning Action Programme at Comilla.
  234. Peripheral venous distensibility and velocity of venous blood flow during oral contraceptive therapy.
  235. Population and family-planning programs in newly developing countries.
  236. Population expansion and birth control: an appropriate problem for high school study.
  237. Pregnancy following withdrawal from oral contraceptive measures.
  238. Preventive psychiatry and family planning.
  239. Progress of family planning in Madras State.
  240. Proposals for family planning promotion: a marketing plan.
  241. Report from Barbados. (Barbados Family Planning Association)
  242. Report from Canada. (Planned Parenthood Association, Toronto)
  243. Report from Ceylon. (The Family Planning Association of Ceylon)
  244. Report from Denmark. (Family planning)
  245. Report from Hong Kong. (The Family Planning Association of Hong Kong.)
  246. Report from India. (The Family Planning Association of India)
  247. Report from Japan. (Family Planning Federation of Japan, Inc.)
  248. Report from Pakistan. (Family Planning Association of Pakistan)
  249. Report from Puerto Rico (Family Planning Association of Puerto Rico)
  250. Report from Singapore. (Family Planning Association, Singapore.)
  251. Report from South Korea. (Planned Parenthood Federation of Korea)
  252. Report from Thailand. (The Family Planning Association of Thailand)
  253. Report from the Federation of Malaya. (Federation of Family Planning Association)
  254. Report from the United Kingdom. (United Kingdom Family Planning Association.)
  255. Report from the United States of America. (Planned Parenthood Federation of America Inc. World Population Emergency Campaign)
  256. Report of study group 2. (Family planning)
  257. A report on some experiences in the Sweden-Ceylon family planning pilot project.
  258. Sample surveys for family planning research in Taiwan.
  259. Some observations on the recent trends in family planning promotion activities in Japan.
  260. Study of patients who registered at Kandang Kerbau family planning clinic, Singapore, during 1958.
  261. Summary of experience with intra-uterine contraceptive devices. (Abstract only)
  262. Superimposition hysterography as a tool in the investigation of intra-uterine contraceptive devices: preliminary report.
  263. Survey of family planning clinics in great Bombay.
  264. The use of an itinerant physician to introduce the intra-uterine contraceptive device in medically disadvantaged areas.
  265. Why does contraception meet so many difficulties in superseding abortion?
  266. Additional measures of use-effectiveness of contraception.
  267. Clinical experience with a new oral contraceptive.
  268. Clinical experiences with norethynodrel and norethisterone as oral contraceptives.
  269. Clinical trial of oral contraceptives Enovid and Conovid E.
  270. Clinical trials on oral contraceptives in Singapore Family Planning Association.
  271. Contact allergic dermatitis in men associated with the use of contraceptives. [Kontaktno-allergicheskii dermatit u muzhchin, svyazannyi s primeneniem protivozachatochnykh sredstv.]
  272. Contraception through the ages.
  273. Contraception using oral progestin-estrogen medication.
  274. Contraceptive effectiveness as a function of desired family size.
  275. The contraceptive pill: a clinical evaluation of its long-term use.
  276. Effect of oral contraceptive (Conovid E) on lactation.
  277. Experiences with Delfen cream as contraceptive method.
  278. Family limitation and methods of contraception in an urban population.
  279. Family planning in India.
  280. Fertility and birth control in developed societies, and some questions of policy for less developed societies.
  281. Field trial of Provest as contraceptive.
  282. How to improve written communication for birth control.
  283. Improved contraception and its mechanisms.
  284. Indicine: hormonal birth control on a natural basis.
  285. Intravaginal contraceptive study: Phase II. Physiology (a direct test for protective potential)
  286. The key role of the male methods of birth control.
  287. The manufacture and retailing of contraceptives in England.
  288. Methods of contraception used in Czechoslovakia. [Jakych antikoncepcnich metod se pouziva v CSR.]
  289. More on family planning: the Consumers Union Report.
  290. A new and practical oral contraceptive agent: norethindrone with mestranol.
  291. A new type of oral contraceptive.
  292. Norethindrone with estrogen as an oral contraceptive: a preliminary report.
  293. Oral contraception and blood coagulability.
  294. Oral contraception and venous thrombosis.
  295. Oral contraception in Latin America.
  296. Oral contraception in practice.
  297. Oral contraception.
  298. Oral contraception. (Letter to the editor)
  299. Oral contraceptives in the immediate puerperium.
  300. Oral contraceptives: results of large scale clinical trials.
  301. Plantae Colombianae. 16. Plants as oral contraceptives in the northwest Amazon.
  302. A preliminary report on the use of oral contraceptive pills synchronised with the phases of the moon.
  303. A proper public policy on birth control.
  304. Some possible effects of birth control on the incidence of disorders and on the influence of birth order.
  305. Tunisia: proposed family planning program.
  306. Varying opinions of the temperature method of birth control. [La diversite des avis dans la methode thermique de limitation des naissances.]
  307. Vasectomy as a preferred method of birth control: a preliminary investigation.
  308. We can end the battle over birth control.
  309. American studies of family planning and fertility: a review of major trends and issues.
  310. Anovlar as an oral contraceptive.
  311. Chemical contraceptive trial.
  312. Chemical contraceptive trial: 2.
  313. Clinical evaluation of a simple jelly-alone method of contraception.
  314. Clinical experience with the use of a flexible nylon ring (Grafenberg ring) as a contraceptive technique.
  315. Clinical trials of oral contraceptives. (Abstract only)
  316. Conception and contraception.
  317. Conovid-E as an oral contraceptive.
  318. Contraception in Japan: discussion on problems of motivation and communication.
  319. Contraception in Japan: problems of motivation and communication.
  320. Contraception of vegetal origin. [Anticonceptionales de origen vegetal.]
  321. Contraception with gel alone.
  322. Contraceptive effectiveness as a function of desired family size.
  323. Contraceptive methods used by couples married in the last thirty years (in Britain)
  324. A critique of the traditional Planned Parenthood approach in underdeveloped areas.
  325. The dai: an essential member of the family planning organization.
  326. The effectiveness of contraceptive foam tablets in an underprivileged urban population in Ceylon.
  327. Evaluating the effectiveness of a family planning program.
  328. Experience with a polyethylene intra-uterine contraceptive device.
  329. Fact finding for birth control action programs.
  330. Family planning in medical practice.
  331. Family planning scheme for Pakistan during the third five year plan period. 1965-1970.
  332. Family planning studies conducted by the Gokhale Institute of Politics and Economics, Poona.
  333. Family planning: outlook for government action in India.
  334. Fertility following termination of contraception with norethindrone.
  335. Field test of simple, foam-producing chemical contraceptive.
  336. General significance of the conference (Family planning)
  337. Highlights of the informal discussion (Family planning)
  338. Improvement of contraception during the course of marriage.
  339. Intra-uterine contraception with plastic devices inserted without cervical dilation.
  340. Intra-uterine contraceptive rings: history and statistical appraisal.
  341. Intrauterine contraceptive devices.
  342. Intravaginal contraceptive study.
  343. Lessons from contraceptive failure.
  344. Medical birth control with ovulation inhibitors. [Die medikamentose Geburtenregelung mit den modernen Ovulationshemmern.]
  345. Minimum standards for clinical studies of intra-uterine contraceptive devices.
  346. A model for family planning action-research.

     

  347. My viewpoints on intra-uterine contraceptive devices.
  348. A new birth control campaign?
  349. Next steps in research on problems of motivation and communication in relation to family planning.
  350. A non-clinical approach to contraception: preliminary report on the program of the Family Planning Association of Puerto Rico.
  351. Norethynodrel as an oral contraceptive: experience in private practice.
  352. Observations on oral contraceptives from Pisum sativum, Linn.
  353. Oral contraceptives and thrombophlebitis.
  354. Oral contraceptives and venous thrombosis.
  355. Outlook for government action in family planning in the West Indies.
  356. Outlook for government action in family planning.
  357. Panel discussion on comparative acceptability of different methods of contraception.
  358. Possibilities and pitfalls in the measurement of attitudes and opinions on family planning.
  359. Post partum sterilisation as a method of family planning.
  360. Practice of contraception and attitudes towards family planning: findings of a sample survey.
  361. Prevention of pregnancy by intra-uterine silkworm contraceptive gut coil.
  362. Problems in procuring contraceptive materials in a rural area in Japan.
  363. Reliability of data relating to contraceptive practices.
  364. Report on study of Margulies' contraceptive spiral.
  365. The role of man in family planning motivation.
  366. Some observations on the use of intra-uterine contraceptive rings in Taiwan (China)
  367. Some procedures for estimating the sampling fluctuations of a contraceptive failure rate.
  368. Some tentative recommendations for a "sociologically correct" family planning communication and motivation program in India.
  369. The stainless steel ring: an effective and safe intra-uterine contraceptive device.
  370. Statistical comparison of intra-uterine contraceptive devices.
  371. A study of intra-uterine contraception: development of a plastic loop.
  372. Study of norethindrone in contraception.
  373. Tolerance to repeated application of a foam contraceptive in the human vagina.
  374. Two cases of thromboembolic disease associated with oral contraceptives.
  375. The use of progestins for oral contraception.
  376. The users of birth control clinics.
  377. In vitro assessment of commercial contraceptive jellies and creams.
  378. The Birmingham oral contraceptive trial.
  379. Birth control from the woman's point of view.
  380. Birth control in Britain Part II.
  381. Birth control in Britain.
  382. A clinical study of a new contraceptive cream-jel.
  383. Clinical trials of oral contraceptives.
  384. Contraception.
  385. The contraceptive pill [letter]
  386. Contraceptive valve of common salt.
  387. The development of contraception in the People's Republic of Macedonia up to the present time.
  388. The emotional resistances to birth control.
  389. Family planning and the Protestant churches in the Netherlands.
  390. Family planning attitudes of industrial workers of Ambarnath, a city of Western India: a comparative analysis.
  391. Family planning in Asia.
  392. A family planning service in rural Puerto Rico.
  393. A family planning survey in four Delhi villages.
  394. Family Planning: the clinic doctor and her patient.
  395. Field trial of a contraceptive foam in Puerto Rico.
  396. A field trial of chemical contraceptives with a group of Italian women from populous urban strata: a report from AIED Rome; separate report to national report Italy.
  397. First report of Nepal Family Planning Association.
  398. Lecture [Cultural, religious, political and legal resistance to family planning]
  399. Lecture [Cultural, religious, political and legal resistance to family planning]
  400. Lecture [Emotional resistance to family planning]
  401. Lecture [Sex education and family planning]
  402. Lecture [The present position with regard to contraceptive technique and research into new methods]
  403. Modern methods of contraception: knowledge and attitudes.
  404. Oral contraception.
  405. An oral contraceptive: a 4-year study of norethindrone.
  406. Parapraxis in contraception.
  407. Patients use Family Planning Association clinics to bring problems that they cannot take anywhere else.
  408. Population, employment and family planning in India.
  409. Psychological and social aspects of family planning (a Muslim Arab point of view)
  410. Psychosomatic aspects of fertility and contraception.
  411. Report of the Family Planning Association of Ceylon.
  412. A short history of the family planning movement in Pakistan: incorporating the annual report of the activities of the Family Planning Association of Pakistan for the years 1958-1959.
  413. Some estimates of the reliability of survey data on family planning.
  414. Some social aspects of family planning (with special reference to the situation in the Netherlands)
  415. Spermicidal effectiveness of chemical contraceptives used with the firm cervical cap.
  416. Supplement to Chapter 5: (contraception)
  417. Evaluation of a new contraceptive.
  418. And the poor get children: sex, contraception, and family planning in the working class.
  419. Birth control and the christian churches.
  420. Birth control by means of SYN-A-GEN.
  421. Birth control practices outside of prostitution before the 18th Century. [Pratiques antinatales hors de la prostitition, anterieures au XVIII siecle.]
  422. Birth control: reversal or postponement?
  423. Diffusion of contraceptive methods. [Sur la diffusion des methodes contraceptives.]
  424. Length of the observation period as a factor affecting the contraceptive failure rate.
  425. New contraceptive gel for use with diaphragm.
  426. Opinions of some casuists of the Counterreformation on abortion, contraception and continence in marriage. [Opinions de quelques casuistes de la contre-reforme sur l'avortement, la contraception et la continence dans le mariage.]
  427. A prescription for family planning: the story of The Pill.
  428. Prostitution: contraceptives and abortifacients. [La prostitution: contraceptifs et abortifs.]
  429. Some experiments on the propagation of family planning in Yeotmal.
  430. The accuracy of reporting on the use of contraception.
  431. Annotated list of published reports on clinical trials with contraceptives.
  432. Birth control.
  433. Birth-control: the right way and the wrong way.
  434. A brief summary of the work done at the government of India family planning training, demonstration and experimental centre, Ramanagaram, Mysore State.
  435. The clinical effectiveness of contraceptive methods.
  436. Clinical studies on intrauterine rings--especially the present state of contraception in Japan and the experiences in the use of intrauterine rings.
  437. Clinical studies with potential oral contraceptives.
  438. Cultural factors and the propagation of family planning in the Indian setting.
  439. Cytology, colposcopy and Schiller iodine test: a combined method for the detection of cervical changes occurring during the use of local contraceptives.
  440. Effectiveness of an oral contraceptive: effects of a progestin-estrogen combination upon fertility, menstrual phenomena, and health.
  441. An enquiry into the prevalence of contraceptive practices in Calcutta City (1956-1957)
  442. Evaluation of a new contraceptive cream-jel based on long-term usage.
  443. Family planning in an Indian village: motivations and methods.
  444. Family planning programme in India.
  445. A family planning service in the West Indies.
  446. Family Planning Training and Research Centre, Bombay.
  447. A field study of motivation to family planning.
  448. Field trials with norethynodrel as an oral contraceptive.
  449. Five-year experiment on family planning among coal miners in Joban, Japan.
  450. Harmlessness tests of chemical contraceptives in rhesus monkeys.
  451. Laboratory evaluation of a new contraceptive gel with trichomonadicidal and moniliastatic properties.
  452. Oral contraceptive for use by both males and females.
  453. The place of surgery in the family planning programme.
  454. Possible lessons from historical experience for family planning programmes in Asia.
  455. Problem of family planning in the countryside: a sociological analysis.
  456. A review of the work of the Contraceptive Testing Unit at the Indian Cancer Research Centre, Bombay.
  457. The role of government in family planning programmes in Pakistan.
  458. Seven years of a family planning programme in three typical Japanese villages.
  459. A study of the effectiveness of contraceptive methods in family planning clinics in India.
  460. Summary of report on work of IPPF sub-committee on tests on contraceptive products.
  461. Surgical methods of contraception in the human female.
  462. Swedish technical assistance for a family planning pilot project in rural areas in Ceylon.
  463. Tolerance studies with a new contraceptive gel.
  464. Willful exposures to unwanted pregnancy (WEUP): psychological explanation for patient failures in contraception.
  465. 7 years of a family planning program in 3 typical Japanese villages.
  466. Combined postpartum and family-planning clinic.
  467. Diffusion spermicidal times of commercial contraceptive jellies and creams secured in 1956.
  468. An oral contraceptive.
  469. Acceptance of family planning in the rural study conducted at Ramanagaram Family Planning Centre.
  470. Agencies which can help family planning programmes.
  471. Attitudes of females toward family planning in a Maharashtrian village.
  472. Birth control and planned families.
  473. Brief talk on the work of the Family Planning Association of Great Britain.
  474. Community education in family planning.
  475. Contraceptive methods applied in family planning clinics in Egypt.
  476. The durability of commercial contraceptive mixtures.
  477. Effect of prolonged administration of spermicidal contraceptives on rats kept on low-protein or on full diet.
  478. Family planning association of India; Report for January 1955- December 1956.
  479. Family planning from the obstetrician's point of view.
  480. Family planning in Egypt.
  481. Family planning work: a practical guide for medico-social workers.
  482. Freedom in contraception: opinion of a demographer. [La liberte de la contraception: opinion d'un demographe.]
  483. Motivation for family planning, with special reference to field studies.
  484. Observations on the clinical use of cream-alone and gel-alone methods of contraception.
  485. Oral contraceptives.
  486. Personnel required for family planning, their functions and training.
  487. Progress of the family planning programme.
  488. Studies in simple methods of contraception.
  489. The work of the Contraceptive Testing Centre of the Government of India.
  490. Clinical effectiveness of a new vaginal contraceptive cream: a preliminary report.
  491. Practical experiences with a foaming-chemical contraceptive. [Praktische Erfahrungen mit einem fermentchemischen Antikonzipiens.]
  492. Action research in family planning.
  493. Birth control in communist China: concerning the problem of dissemination of knowledge about contraception.
  494. Clinical tests of chemical contraceptives.
  495. Cultural barriers to family planning in under-developed countries.
  496. Development programmes and planned parenthood in Asian countries.
  497. Effects of a vaginally applied contraceptive with phenylmercuric acetate upon developing embryos and their mother animals.
  498. Eugenics in relation to planned parenthood.
  499. Family planning and eugenic movements in the mid-twentieth century.
  500. Family planning and the new life movement.
  501. Family planning guidance in the Joban Coal Mining Company.
  502. Family planning in the social set-up of Ceylon.
  503. Family Planning problems in the plantations.
  504. Five years of family planning in three Japanese villages.
  505. Further clinical results with metaxylohydroquinone as an oral contraceptive.
  506. The importance of the family planning movement in the field of the rational living campaign.
  507. An improved test of spermicidal activity and its application to commercial contraceptive preparations.
  508. Japanese mothers and birth control.
  509. The Margaret Sanger story and the fight for birth control.
  510. Pregnancy rates during the use of contraception in India and Pakistan.
  511. Promotion of family planning through public health centers.
  512. Promotion of the family planning program in Japan from the prefectural standpoint.
  513. Recent trend of family planning movement in Japan.
  514. A reflection upon the birth control movement during the last five and a half years.
  515. A report on the present state of birth control in Osaka Prefecture.
  516. Results of birth control practice in the city of Kobe.
  517. Spermicidal activity of undiluted commercial contraceptive preparations, 1953.
  518. Effectiveness of Preceptin: study of its use as sole contraceptive agent in an urban clinic population.
  519. Practical experience with a new vaginal contraceptive.
  520. Prosperity and parenthood: a study of family planning among the Victorian middle classes.
  521. Discussion about a modern contraceptive on biological basis.
  522. The effectiveness of the cervical cap as a contraceptive method.
  523. The postcoital test as a method of evaluating a contraceptive jelly.
  524. Birth control and abortion in France since 1939.
  525. The clinical effectiveness of contraception.
  526. Clinical experience with a new gel-alone method of contraception.
  527. Concerning chemical Contraceptive means, II. [Om kemiske anticonceptionelle midler, II.]
  528. A critical study of the efficacy of jelly as a contraceptive.
  529. Report to the World Health Organization on family planning in India.
  530. The clinical effectiveness of the rhythm method of contraception.
  531. Notes on abortion and birth control in Germany.
  532. A study of a simple contraceptive method for clinic and private patients.
  533. A vaginal jelly alone as a contraceptive in postpartum patients.
  534. Further observations on the suppository as a contraceptive.
  535. Community factors in family planning.
  536. Contraception among two thousand private obstetric patients.
  537. Contraception with an intrauterine silk coil.
  538. Conception control and the medical profession. The attitude of 3381 physicians toward contraception and the contraceptives they prescribe.
  539. The condom as a contraceptive method in public health work.
  540. The effectiveness of a simple contraceptive method.
  541. Jelly-alone as a contraceptive in post-partum cases.
  542. The teaching of contraception in medical schools. (Editorial)
  543. Contraception and fertility in the southern Appalachians.
  544. The contraceptive service of the department of health, City of Nashville.
  545. Fertility and contraception in Puerto Rico.
  546. Contraceptive service in three areas: Part 1. The clinics and their patients.
  547. Vaginal insufflation of a powder as a method of contraception.
  548. Birth control and population trends.
  549. Contraception and planned parenthood in a private practice.
  550. A method of testing the relative spermicidal effectiveness of contraceptives, and its application to ten commercial products.
  551. Various methods of contraception.
  552. Birth control in a midwestern city.
  553. Birth control in a Midwestern city. A study of the clinics of the Cincinnati Committee on Maternal Health. 1. Contraception and fertility before clinic attendance.
  554. Birth control in a Midwestern city. A study of the clinics of the Cincinnati Committee on Maternal Health. 2. The effectiveness of contraception after clinic attendance.
  555. The effects upon natural fertility of contraceptive efforts.
  556. The extent of the contraceptive effort in the American population.
  557. Contraception in private practice: a 12 year experience.
  558. The clinical effectiveness of lactic acid jelly as a contraceptive.
  559. Some psychiatric aspects of birth control.
  560. Contraceptive jellies: a clinical study.
  561. Contraception and fertility in 4945 married women. A 2nd report on a study of family limitation.
  562. A study on the birth control with an intrauterine instrument.
  563. Contraception and fertility in 2000 women.
  564. Anjea: infanticide, abortion and contraception in savage society.
  565. An intrauterine contraceptive method.
  566. My fight for birth control.
  567. The spermicidal powers of chemical contraceptives: 3 pessaries.
  568. The "safe period" as a birth control measure: A study and evaluation of available data.
  569. Birth control methods.
  570. The intrauterine contraceptive pessary - inefficient and dangerous.
  571. Contraceptive technique: a consideration of 1,400 cases.
  572. Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive.
  573. Lateness of contraception among recipients of subsidized family planning service.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.